(MEDTECH DIVE) – Orthopedics companies such as Johnson & Johnson benefited from rising procedure volumes in the second quarter, even as foreign-exchange rates, material costs and supply chain issues continued to weigh on their earnings. […]
(CalMatters) – As a third of hospitals report critical staffing shortages, California’s health department is considering issuing an order postponing many elective surgeries. Many procedures, including a lung transplant, already have been canceled. […]
(MedTech Dive) – Smith+Nephew, Stryker and Zimmer Biomet have rounded out the current earnings season with third-quarter results, revealing how the orthopaedics industry remains constrained by COVID-19, hospital staffing shortages and lower pricing in China. […]
(Forbes) – New chief executives typically face plenty of challenges, whether they be turning around a company that has lost its way or maintaining the momentum established by a predecessor. […]
(MD+DI) – The orthopedics market has been on a wild ride since the beginning of the pandemic. Shutdowns and uncertainty with elective procedures, which include but are not limited to orthopedics, have put a lot of twists and turns in the market. […]
(MEDTECH DIVE) – J&J, Smith & Nephew and Stryker reported seeing a light at the end of the tunnel during the first quarter as nonessential care rebounded, with a backlog of hip procedures pointing the way forward. […]
Copyright © 2022 | MH Magazine WordPress Theme by MH Themes